This page shows the details of why an item matched the keywords from your search.
| Property | Value |
|
has major subject area list
|
Anemia; Multiple Myeloma
|
|
information resource reference
|
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial. Nat Med. 2023 10; 29(10):2570-2576.
|
|
label
|
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial.
|